Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Real-world feasibility of adapted European Respiratory Society asthma diagnosis guidelines for school-aged children.

ERJ open research·2026
Same author

Dissemination and Influence of the International Family Nursing Association Position Statements: A Scoping Review.

Journal of family nursing·2026
Same author

[Childhood and adolescent adversity : from toxic stress to clinical practice].

Revue medicale suisse·2026
Same author

[Health of migrant children: practical tools for pediatric practice].

Revue medicale suisse·2026
Same author

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis.

Pediatric pulmonology·2026
Same author

Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis.

Therapeutic advances in respiratory disease·2025

Video Experimental Relacionado

Updated: Feb 20, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

16.0K

Enfoque sistémico en pediatría: contextualizando la complejidad de las interacciones

Laurence Di Benedetto1, Pierre Ruffieux2, Charlotte Reith1

  • 1Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Revue medicale suisse
|February 19, 2026
PubMed
Resumen

Un paciente

Palabras clave:
enfermedadfamiliasistemaspediatríaadaptaciónhomeostasisenfoque sistémico

Más Videos Relacionados

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

924
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.5K

Videos de Experimentos Relacionados

Last Updated: Feb 20, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

16.0K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

924
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.5K

Área de la Ciencia:

  • Teoría de Sistemas Familiares
  • Sociología Médica
  • Psicología de la Salud

Sus antecedentes:

  • La salud del paciente está influenciada por los sistemas familiares, sociales y médicos interconectados.
  • La enfermedad, particularmente en niños, altera significativamente la dinámica y los roles familiares establecidos.
  • Las familias, al igual que los organismos, se adaptan a la enfermedad buscando la homeostasis y modificando las interacciones internas/externas.

Objetivo del estudio:

  • Explorar el impacto de la enfermedad del paciente en los sistemas familiares.
  • Comprender los procesos adaptativos que atraviesan las familias durante la enfermedad de un paciente.
  • Destacar la utilidad de un enfoque sistémico para los profesionales de la salud.

Principales métodos:

  • Análisis cualitativo de las interacciones y dinámicas familiares.
  • Observación de las etapas del ciclo vital familiar (crisis, transición, estabilización).
  • Aplicación de la teoría sistémica para comprender las relaciones paciente-sistémicas.

Principales resultados:

  • Los sistemas familiares exhiben una influencia recíproca con el paciente, lo que impacta los resultados generales de salud.
  • La enfermedad desencadena un proceso dinámico de adaptación, modificación de roles y restablecimiento del equilibrio dentro de la unidad familiar.
  • Los cuidadores observan fases distintas en la adaptación familiar a la enfermedad.

Conclusiones:

  • Un enfoque sistémico mejora la comprensión profesional de las interacciones paciente-sistémicas.
  • Identificar recursos, necesidades y dificultades dentro de los sistemas interconectados es crucial para la co-construcción de soluciones efectivas.
  • La formación en enfoques sistémicos capacita a los profesionales para apoyar mejor a los pacientes y sus familias durante la enfermedad.